Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 9
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.
Journal of the National Comprehensive Cancer Network : JNCCN.
Times cited: 10
- Open-label study of oral CEP-701 (lestaurtinib) in patients with polycythaemia vera or essential thrombocythaemia with JAK2-V617F mutation. British journal of haematology. 2014 Academic Article GET IT
- Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms. Cancer research. 2013 Academic Article GET IT
- Case 15-2006: The Budd-Chiari syndrome and V617F mutation in JAK2 . The New England journal of medicine. 2006 Information Resource GET IT